Distribution Services · Medical Distributors · NSE: BALAXI · data 2026-10-09
Balaxi Pharmaceuticals Limited
Health check: Weak (1.5/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹22.33
Market cap
₹122 cr
P/E
—
P/B
—
ROE
0.6%
ROCE
—
Debt / equity
0.23
Dividend yield
0.00%
1-year return
-48.3%
52-week high
₹44.36
52-week low
₹15.2
Operating margin
—
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | -7.0% |
| Profit growth, 3 years (yearly) | -68.6% |
Chart patterns
- Double top — forming (key level ₹21.5)
Similar companies
QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Aakaar Medical Technologies Limited (AAKAAR) · Vivo Bio Tech Ltd. (VIVOBIOT) · Mono Pharmacare Limited (MONOPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BALAXI in NSE Scanner →